Gilead Sciences, Inc. (GILD)
129.58
-2.48
(-1.88%)
USD |
NASDAQ |
May 15, 16:00
129.69
+0.11
(+0.08%)
After-Hours: 20:00
Gilead Sciences Shareholders Equity (Quarterly) : 23.52B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.19B |
| Biogen, Inc. | 18.65B |
| AbbVie, Inc. | -6.656B |
| Moderna, Inc. | 7.408B |
| Abbott Laboratories | 52.06B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 56.28B |
| Total Liabilities (Quarterly) | 32.85B |
| Debt to Equity Ratio | 0.943 |
| Current Ratio | 1.967 |
| Net Debt Paydown Yield | 0.59% |